Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 4.5 Million AUD | 72.16% |
| 2022 | 2.61 Million AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.48 Million AUD | 0.0% |
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q1 | 5.48 Million AUD | 677.15% |
| 2024 FY | - AUD | -100.0% |
| 2023 Q1 | 1.5 Million AUD | 15.01% |
| 2023 FY | 4.5 Million AUD | 72.16% |
| 2023 Q4 | 705.81 Thousand AUD | 0.0% |
| 2023 Q3 | 705.81 Thousand AUD | -53.1% |
| 2023 Q2 | 1.5 Million AUD | 0.0% |
| 2022 Q4 | 1.3 Million AUD | 0.0% |
| 2022 FY | 2.61 Million AUD | 0.0% |
| 2022 Q3 | 1.3 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |